Boston Scientific Corporation (BSX)
Company Info
Highlights
$130.76B
$1.21
73.32
1.60
$15.91B
$10.71B
$3.82B
$53.56 - $89.01
$97.77
0.77%
2.06
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Boston Scientific Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Boston Scientific Corporation had a return of 50.48% year-to-date (YTD) and 60.08% in the last 12 months. Over the past 10 years, Boston Scientific Corporation had an annualized return of 21.05%, outperforming the S&P 500 benchmark which had an annualized return of 11.16%.
BSX
50.48%
-1.23%
16.53%
60.08%
15.38%
21.05%
^GSPC (Benchmark)
23.62%
0.54%
11.19%
30.63%
13.61%
11.16%
Monthly Returns
The table below presents the monthly returns of BSX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 9.43% | 4.66% | 3.44% | 4.94% | 5.15% | 1.91% | -4.06% | 10.71% | 2.46% | 0.26% | 50.48% | ||
| 2023 | -0.04% | 1.02% | 7.08% | 4.18% | -1.23% | 5.07% | -4.14% | 4.03% | -2.11% | -3.05% | 9.18% | 3.44% | 24.94% |
| 2022 | 0.99% | 2.96% | 0.27% | -4.92% | -2.61% | -9.12% | 10.14% | -1.80% | -3.92% | 11.31% | 5.01% | 2.21% | 8.92% |
| 2021 | -1.42% | 9.42% | -0.34% | 12.81% | -2.41% | 0.49% | 6.64% | -0.99% | -3.90% | -0.60% | -11.73% | 11.58% | 18.16% |
| 2020 | -7.41% | -10.70% | -12.73% | 14.86% | 1.36% | -7.58% | 9.85% | 6.35% | -6.85% | -10.31% | -3.27% | 8.45% | -20.50% |
| 2019 | 7.95% | 5.16% | -4.34% | -3.28% | 3.48% | 11.90% | -1.21% | 0.64% | -4.77% | 2.48% | 3.72% | 4.55% | 27.96% |
| 2018 | 12.79% | -2.50% | 0.22% | 5.12% | 5.81% | 7.60% | 2.78% | 5.80% | 8.27% | -6.13% | 4.23% | -6.19% | 42.56% |
| 2017 | 11.23% | 2.04% | 1.30% | 6.07% | 2.46% | 2.55% | -3.97% | 3.49% | 5.88% | -3.53% | -6.61% | -5.67% | 14.61% |
| 2016 | -4.93% | -3.14% | 10.78% | 16.53% | 3.60% | 2.91% | 3.89% | -1.89% | -0.08% | -7.56% | -7.00% | 5.72% | 17.30% |
| 2015 | 11.77% | 14.11% | 5.03% | 0.39% | 2.53% | -3.12% | -2.03% | -3.46% | -1.97% | 11.40% | -0.00% | 0.88% | 39.17% |
| 2014 | 12.56% | -3.18% | 3.21% | -6.73% | 1.74% | -0.47% | 0.08% | -0.78% | -6.86% | 12.45% | -3.09% | 2.95% | 10.23% |
| 2013 | 30.37% | -1.07% | 5.68% | -4.10% | 23.36% | 0.32% | 17.80% | -3.11% | 10.96% | -0.43% | -0.94% | 3.80% | 109.77% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current risk-adjusted rank of BSX is 99, placing it in the top 1% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Boston Scientific Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Boston Scientific Corporation was 89.15%, occurring on Jul 26, 2012. Recovery took 2268 trading sessions.
The current Boston Scientific Corporation drawdown is 2.01%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -89.15% | Apr 6, 2004 | 2093 | Jul 26, 2012 | 2268 | Aug 2, 2021 | 4361 |
| -73.66% | Jul 19, 1999 | 353 | Dec 6, 2000 | 570 | Mar 20, 2003 | 923 |
| -58.38% | Jan 27, 1993 | 177 | Oct 7, 1993 | 361 | Mar 14, 1995 | 538 |
| -47.77% | Aug 20, 1998 | 57 | Nov 9, 1998 | 89 | Mar 19, 1999 | 146 |
| -46.02% | Aug 7, 1997 | 95 | Dec 19, 1997 | 134 | Jul 6, 1998 | 229 |
Volatility
Volatility Chart
The current Boston Scientific Corporation volatility is 4.71%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Boston Scientific Corporation compared to its peers in the Medical Devices industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for BSX in comparison to other companies of the Medical Devices industry. Currently, BSX has a PE value of 73.3. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for BSX in comparison to other companies of the Medical Devices industry. Currently, BSX has a PEG value of 1.6. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Boston Scientific Corporation.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |